SKSuna Koc

Suna Koc

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Suna Koc has a total of 100 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Comparison of QLB block and TAP block in morbid obese patients: a randomized controlled study

    by Suna Koc, Sevcan Buyuk, Pınar Acar, Selcuk Alver, Mehmet A. Ozturk, Mehmet Dokur, Mehmet I. Buget

  • Open Access

    Correction: Yenmis et al. The Distribution of Sport Performance Gene Variations Through COVID-19 Disease Severity. Diagnostics 2025, 15, 701

    by Guven Yenmis, Ilayda Kallenci, Mehmet Dokur, Suna Koc, Sila Basak Yalinkilic, Evren Atak, Mahmut Demirbilek, Hulya Arkan

  • Open Access

    Clinical and Laboratory Predictors of Mortality in Critically Ill Patients with COVID-19 Incorporating Post-COVID-19 Condition: A Retrospective Cohort Study

    by Turkan Guney, Suna Koc, Nurcan Arikan, Mehmet Dokur, Efe Sezgin, Sema Nur Dokur, Sena Gul Koc

    Background: COVID-19 manifested with a wide range of clinical symptoms, including asymptomatic or mild illness and life-threatening respiratory failure. We hypothesized that elevated predictors during intensive care unit (ICU) stays would independently predict mortality and the subsequent development of post-COVID-19 condition (PCC). Methods: In this retrospective cohort study, we evaluated the clinical and laboratory determinants of mortality using hospital records in severe COVID-19 patients in conjunction with their PCC in survivors by self-reported survey. This research was conducted at XX University Hospital, and adult patients with laboratory-confirmed SARS-CoV-2 infection by RT-PCR assay who required ICU admission for respiratory failure or hemodynamic instability were included. Biomarkers were monitored throughout ICU stay to evaluate dynamic changes and their association with mortality. Survivors were followed from ICU discharge to assess readmissions, vaccination status, and post-COVID-19 condition, including fatigue, sleep disturbance, physical exhaustion, concentration problems, and memory impairment. Post-ICU mortality and hospitalization due to cardiovascular, respiratory, neurological, or other complications were recorded. Results: A total of 273 critically ill patients were included, of whom 112 survived and 161 died during ICU stay. Non-survivors were older and had lower mean arterial pressure. Intubation was more frequent among non-survivors, and APACHE II scores were significantly higher in this group. Hospitalizations due to cardiovascular, respiratory, and neurological complications were particularly associated with increased hazard of death (HRs ≥2, p-values < 0.05). Patients who died after ICU discharge (31.5%) had higher rates of fatigue, physical exhaustion, and memory impairment, suggesting a strong correlation between biomarker derangements during ICU stay and PCC. Conclusions: The present study was specifically designed to address this critical gap by evaluating whether biomarker trajectories during ICU follow-up not only predict in-hospital mortality but also serve as early determinants of Post-COVID status in survivors.

  • Prognostic Role of Blood Gas Analysis in Missed Prehospital Diagnoses Among Critically Ill Patients: A Pioneering Study

    by Turkan Guney, Mehmet Dokur, Suna Koc, Mehmet Karadag

    Amaç: Bu çalışmanın amacı, hastane öncesi tanı konulmamış ancak acil müdahale gerektiren kritik durumdaki hastalar için kaza veya olay yerinden mümkün olan en kısa sürede kan gazı parametrelerini öğrenmenin ne kadar önemli olduğunu ortaya koymaktır. Yöntemler: Bu klinik çalışmada, farklı zamanlarda hastanemizin acil servisine getirilen 16 kritik hastanın geçmişe dönük olarak pH, SO₂, FHHb, glikoz ve laktat gibi kan gazı parametreleri ile demografik ve kritik tanı bilgileri incelenmiştir. Verilerin normal olup olmadığını görmek için Shapiro-Wilk testi adlı istatistiksel test kullanılmıştır. Grupları karşılaştırmak için Student t-testi veya Mann-Whitney U testi kullanılmıştır. Bulgular: Demografik özellikler açısından, hastaların ortalama yaşı 56,9±22,1 idi ve %81,2'si erkekti. Resüsitasyon ve mortalite oranları sırasıyla %87,5 ve %68,8 idi. Kan gazı parametreleri ile mortalite arasında anlamlı ilişkiler bulunmuştur. Ölen hastalar daha düşük pH (p = 0,025) ve SO₂ düzeyleri (p = 0,046) sergilerken, FHHb (p = 0,018), glikoz (p = 0,031) ve laktat düzeyleri (p = 0,014) anlamlı olarak daha yüksek bulunmuştur. Sonuçlar: Bu klinik çalışmanın sonuçları, kritik hastalarda hastalık şiddeti ve klinik seyir açısından kan gazı parametrelerinin erken bilinmesinin önemini göstermektedir. Kan gazı parametrelerine erken erişim, hastaneye ulaşmadan önce tanının kaçırılmasını önlemeye yardımcı olabilir ve hayat kurtaran tedavilerin hemen başlatılması için klinik karar verme sürecini hızlandırabilir.

  • Open Access

    Is Altered Surfactant Protein Gene Expression in Peripheral Blood Associated with COVID-19 Disease Severity?

    by Suna Koc, Kamil Cankut Senturk, Sefa Cetinkaya, Guven Yenmis, Hulya Arkan, Mahmut Demirbilek, Pinar Acar, Erhan Arikan, Mehmet Dokur

    Background/Objectives: Severe COVID-19 pneumonia damages alveolar type II cells and disrupts surfactant homeostasis, contributing to acute respiratory distress syndrome (ARDS). Surfactant proteins (SP-A, SP-B, SP-C, SP-D) are critical for reducing alveolar surface tension and for innate immune defense. We aimed to evaluate whether surfactant protein gene expression varies with the severity of COVID-19. Methods: Peripheral blood was collected from 122 adults with confirmed COVID-19, categorized as asymptomatic (no symptoms), mild (requiring hospitalization), or severe (requiring ICU admission). We quantified mRNA expression of surfactant protein genes (SFTPA1, SFTPA2, SFTPB, SFTPC, SFTPD) in blood cells using RT-qPCR. Relative expression was normalized to GAPDH and compared among the groups using the 2−ΔΔCt method. Outliers (Ct values > 3 SD from the mean) were excluded before analysis. Results: Distinct surfactant gene expression patterns were markedly associated with disease severity. Transcripts of SFTPB and SFTPC decreased with increasing severity of the disease. Notably, SFTPC expression was ~49-fold higher in mild cases compared to asymptomatic COVID-19-positive patients (p < 0.0001), but then decreased by ~54-fold in severe cases relative to mild (p < 0.0001), returning to near-baseline levels. In contrast, SFTPA2 and SFTPD were dramatically upregulated in severe cases. SFTPA2 was ~50-fold higher in severe versus mild cases (p < 0.0001), and SFTPD was ~4346-fold higher in severe versus asymptomatic cases (p < 0.0001; ~9.6-fold higher than in mild). SFTPA1 showed only a modest ~1.4-fold decrease in severe cases (vs. mild). All noted differences remained statistically significant after outlier exclusion. Conclusions: COVID-19 severity is correlated with profound changes in surfactant gene expression in blood. Critically ill patients exhibit loss of key surfactant components (SP-B and SP-C transcripts) alongside an excessive SP-D response. These preliminary findings suggest an imbalance that may contribute to lung injury in severe disease. However, further validation is needed to establish surfactant proteins, such as SP-D, as biomarkers of COVID-19 severity.


  • Open Access

    Altered Surfactant Protein Gene Expression in Peripheral Blood Is Associated with COVID-19 Disease Severity

    by Suna Koc, Kamil Cankut Senturk, Sefa Cetinkaya, Guven Yenmis, Hulya Arkan, Mahmut Demirbilek, Pinar Acar, Erhan Arikan, Mehmet Dokur

    Background/Objectives: Severe COVID-19 pneumonia causes alveolar type II cell damage and surfactant dysfunction, contributing to acute respiratory distress syndrome (ARDS). Surfactant proteins (SP-A, SP-B, SP-C, SP-D) are critical for reducing alveolar surface tension and defending against infection. We aimed to evaluate how surfactant protein gene expression affects COVID-19 severity Methods: Peripheral blood was collected from 122 adults with confirmed COVID-19, categorized as asymptomatic (no symptoms), mild (hospitalized), or severe (ICU admission). We quantified mRNA expression of surfactant protein genes (SFTPA1, SFTPA2, SFTPB, SFTPC, SFTPD) by RT-qPCR and compared relative expression levels between groups. Results: Surfactant gene expression patterns differed markedly with disease severity. SFTPB and SFTPC transcripts decreased as severity increased. Notably, SFTPC was ~49-fold higher in mild cases than asymptomatic controls, but then dropped ~54-fold in severe cases relative to mild, returning to near-baseline levels. In contrast, SFTPA2 and SFTPD were dramatically upregulated in severe illness. SFTPD expression in severe patients was ~4346-fold higher than in asymptomatic individuals (and ~9.6-fold higher than in mild cases). SFTPA2 was ~50-fold higher in severe versus mild cases. By comparison, SFTPA1 showed a modest ~1.4-fold decrease in severe cases (vs. mild). All noted differences were statistically significant (p < 0.05). Conclusion: COVID-19 severity is associated with distinct surfactant gene expression changes. Critically ill patients exhibited loss of key surfactant components (SP-B and SP-C) alongside an excessive SP-D response. This imbalance in the surfactant system likely contributes to alveolar collapse in severe COVID-19, and elevated SP-D may serve as a biomarker of lung injury severity.


  • Open Access

    The Distribution of Sport Performance Gene Variations Through COVID-19 Disease Severity

    by Guven Yenmis, Ilayda Kallenci, Mehmet Dokur, Suna Koc, Sila Basak Yalinkilic, Evren Atak, Mahmut Demirbilek, Hulya Arkan

    Background/Objectives: Since its emergence in 2020, researchers worldwide have been collaborating to better understand the SARS-CoV-2 disease’s pathophysiology. Disease severity can vary based on several factors, including comorbidities and genetic variations. Notably, recent studies have highlighted the role of genes associated with athletic performance, such as ACE, ACTN3, and PPARGC1A, in influencing muscle function, cardiovascular health, and the body’s metabolic response. Given that these genes also impact oxidative metabolism, inflammation, and respiratory efficiency, we hypothesized that they might play a critical role in the host’s response to SARS-CoV-2 infection. This study aimed to investigate the association between disease severity and genetic polymorphisms in these sport performance-related genes, specifically ACE rs4646994, ACTN3 rs1815739, and PPARGC1A rs8192678. Methods: A total of 422 COVID-19-positive patients were included in this study. The participants were divided into three groups: a severe group (77 patients) requiring intensive care unit (ICU) admission, a mild group (300 patients) exhibiting at least one symptom, and an asymptomatic control group. Genotyping was performed using restriction fragment length polymorphism PCR. Results: The D allele and DD genotype of ACE and the T allele and TT genotype of ACTN3 were found to confer protective effects against severe SARS-CoV-2 infection. Conversely, the PPARGC1A TC genotype and the ACE-PPARGC1A ins/ins + TC combined genotype were associated with increased disease severity (p < 0.05). Conclusions: Although vaccination has reduced the severity of SARS-CoV-2, the virus continues to impact human health. Inter-individual differences due to these genetic variations will broaden the horizon of knowledge on the pathophysiology of the disease.


  • Open Access

    Investigation of the Relationship between Vitamin D Deficiency and Vitamin D-Binding Protein Polymorphisms in Severe COVID-19 Patients

    by Lutfiye Karcıoğlu Batur, Mehmet Dokur, Suna Koç, Mehmet Karabay, Zeyneb Nur Akcay, Ezgi Gunger, Nezih Hekim

    This study explores the association of vitamin D-binding protein (VDBP) gene polymorphisms, vitamin D levels, and the severity of COVID-19, including the need for intensive care unit (ICU) hospitalization. We analyzed a cohort of 56 consecutive age- and gender-matched adult COVID-19-positive patients and categorized them into three groups: outpatients with mild illness, inpatients with moderate disease, and ICU patients. We measured levels of free, total, and bioavailable 25-hydroxyvitamin D [25(OH)D], VDBP, and albumin. VDBP polymorphisms rs5488 and rs7041 were identified using real-time PCR. A significant proportion of ICU patients were vitamin D-deficient (56.25%) compared to outpatients (10%) and inpatients (5%) (p = 0.0003). ICU patients also had notably lower levels of VDBP (median: 222 mg/L) and total 25(OH)D (median: 18.8 ng/mL). Most patients carried heterozygous rs7041 (60.7%) and wild-type rs4588 (58.9%) genotypes. The distribution of rs7041 SNP varied significantly among groups (p = 0.0301), while rs4588 SNP distribution did not (p = 0.424). Heterozygous rs4588 patients had significantly lower VDBP levels (p = 0.029) and reduced bioavailable 25(OH)D compared to those with wild-type rs4588 (p = 0.020). Our findings indicate that VDBP gene polymorphisms, particularly rs7041 and rs4588, are associated with vitamin D status and the severity of COVID-19. The lower VDBP levels and bioavailable vitamin D in ICU patients suggest that these genetic variants may influence disease severity and hospitalization needs. These results highlight the potential role of VDBP polymorphisms in COVID-19 severity, suggesting that genetic screening could be valuable in assessing the risk of severe outcomes and guiding personalized treatment strategies.


  • Open Access

    Association between Vitamin D Status and Secondary Infections in Patients with Severe COVID-19 Admitted in the Intensive Care Unit of a Tertiary-Level Hospital in Turkey

    by Lutfiye Karcioglu Batur, Suna Koç

    There are several studies showing that the vitamin D status can determine risk of COVID-19 infections, severity and mortality from coronavirus disease 2019 (COVID-19). However, the association between vitamin D (25(OH)D) and secondary infections in the prognosis of COVID-19 patients has not been reported yet. The aim was to investigate whether the vitamin D status affects the rates of secondary infections in patients with severe COVID-19 hospitalized in the intensive care unit (ICU) of a tertiary-level hospital in Turkey. The data of 194 patients with diagnosis of severe COVID-19 who were admitted to the ICU from March 2020 to June 2021 and older than 18 years were evaluated in this retrospective study. The patients were divided into two groups according to total serum 25(OH)D level as normal group (≥20 ng/mL) and low group (p = 0.013). The systolic and diastolic blood pressure as well as the Glasgow coma scale score of the low group were significantly lower than that of the normal group (p = 0.004, 0.002 and 0.001, respectively). The intubation rate and APACHE (Acute Physiology and Chronic Health Evaluation) score of the low group was significantly higher than that of the normal group (p = 0.001). The platelets number and blood pH decreased, and the neutrophil/lymphocyte ratio, procalcitonin, lactate, urea, creatinine and lactate dehydrogenase concentrations increased significantly in the low group (p < 0.05). The mortality rate was 79.7% in the low group and 22.4% in the normal group (p < 0.001). Microbiological growth was observed in 68.6% of the normal group and 52.6% of the normal group (p = 0.025). The number of cultures with resistant bacteria was significantly higher in the low group (25.9%) than that in the normal group (17.5%) (p = 0.035). The severe COVID-19 patients hospitalized with vitamin D deficiency may have increased risks of poor prognosis and mortality due to secondary infections in the ICU.


  • Association between ABO blood types and the prognosis and mortality rates in patients with severe COVID-19 admitted in the intensive care unit of a tertiary-level hospital in Turkey

    by Suna Koç, Lutfiye Karcioglu Batur

    There is limited number of data showing possible correlation between ABO blood types and prognosis and mortality of COVID-19 patients. It was aimed to investigate whether ABO blood group type affects the prognosis and mortality rates in patients with severe COVID-19 hospitalized in the ICU (intensive care unit) of a tertiary-level hospital in Turkey. The data of 273 patients with diagnosis of severe COVID-19 who were admitted to ICU from April 2020 through June 2021 and in an age range between 25-93 years were evaluated in this retrospective study. Blood group distribution was 47.3%, 13.2%, 10.6% and 28.9% for groups A, B, AB, and O, respectively. As a respiratory status at admission to ICU; the ratio of intubation patients with blood type O was significantly higher than of other groups while most of patients in group A achieved spontaneous respiration without any mechanical ventilator (P = 0.0168). The mean neutrophil ratio, NLR, concentrations of procalcitonin, lactate, urea and ferritin significantly increased in the serum of patients with type O (P < 0.01 for all except P = 0.016 for the ferritin). The weaning duration was longest among patients with blood group O while the hospitalization duration was longest among patients with group AB, however, there was not significant difference (P > 0.05). The highest mortality rate was calculated in group AB as 68.97% and lowest was 47.2% in group B without any statistical difference (P > 0.05). ABO blood types carry different association risk factors for the prognosis of severe COVID-19 patients hospitalized in ICU. Specifically, blood group O was correlated with an increased risk of deterioration of respiratory status including intubation and elevation of laboratory findings whereas it did not affect the risk of increased mortality.